Company Filing History:
Years Active: 2013
Title: André Haeberli: Innovator in Proteolytic Enzyme Detection
Introduction
André Haeberli is a notable inventor based in Gümligen, Switzerland. He has made significant contributions to the field of biomedical technology, particularly in the detection of proteolytic enzymes in bodily fluids. His innovative work has the potential to impact medical diagnostics and treatment.
Latest Patents
Haeberli holds a patent for a "System for differential determination of a proteolytic enzyme level in a bodily fluid." This system includes an assortment of sensors, where the working electrode of each sensor is covered with a specific reagent of a given proteolytic enzyme. The system is designed to measure the release of leaving groups (LG) via the action of the enzyme. It features a measuring apparatus with an electronic circuit that imposes a current, and an electronic apparatus for processing the transmitted signal. This technology can be utilized to determine factors responsible for coagulation anomalies in plasma or whole blood samples.
Career Highlights
André Haeberli is associated with Asulab S.A., where he continues to develop innovative solutions in the field of medical diagnostics. His work is characterized by a commitment to advancing technology that can improve patient outcomes.
Collaborations
Haeberli collaborates with talented professionals in his field, including Charles Thürlemann and Erik Jan Frenkel. These partnerships enhance the development and application of his innovative technologies.
Conclusion
André Haeberli's contributions to the field of proteolytic enzyme detection exemplify the impact of innovation in medical technology. His work not only advances scientific understanding but also holds promise for improving healthcare diagnostics.